Email me when PFM Health Sciences, LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| OM | Outset Medical, Inc. | Common Stock, par value $0.001 per share (the "Shares") | 9.4% | $14.1M | 25M | PFM Health Sciences, LP | Mar 10, 2025 | ||
| HOWL | Werewolf Therapeutics, Inc. | Common stock, par value $0.0001 per share (the "Shares") | 0.9% | $533K | -$3.33M | 401K | -86.2% | PFM Health Sciences, LP | Jun 30, 2025 |
| PMVP | PMV Pharmaceuticals, Inc. | Common stock, par $0.00001 per share (the "Shares") | 0% | $0 | -$4.69M | 0 | -100% | PFM Health Sciences, LP | Jun 30, 2025 |
| EPIX | ESSA Pharma Inc. | Common Shares, no par value per share (the "Shares") | 0% | $0 | 0 | PFM Health Sciences, LP | Dec 31, 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|